Vitamin A

Vitamin A is a vitamin, an essential nutrient for humans. It is a group of unsaturated organic compounds that includes retinol, retinal, (also known as retinaldehyde), retinoic acid and several provitamin A carotenoids (most notably beta-carotene).[2][3][4] Vitamin A has multiple functions: it is important for growth and development, for the maintenance of the immune system, and essential for vision, where it combines with the protein opsin to form rhodopsin, the light-absorbing molecule necessary for both low-light (scotopic vision) and color vision.[5][6][7]

All forms of vitamin A have a β-ionone ring to which an isoprenoid chain is attached, called a retinyl group.[2] Both structural features are essential for vitamin activity. β-carotene can be represented as two connected retinyl groups, which are used in the body to contribute to vitamin A levels.[4]

Vitamin A can be found in two principal forms in foods:

  • Retinol, the form of vitamin A absorbed when eating animal food sources, is a yellow, fat-soluble substance. Since the pure alcohol form is unstable, the vitamin is found in the liver and other organs in a form of retinyl ester.[2] It is also commercially produced and administered as esters, such as retinyl acetate or palmitate.
  • The carotenes – alpha-carotene, β-carotene, gamma-carotene, and the xanthophyll, beta-cryptoxanthin (all of which contain β-ionone rings) – but no other carotenoids, function as provitamin A in herbivores and omnivore animals,[2] which possess the enzyme beta-carotene 15,15′-dioxygenase to cleave and convert provitamin A to retinol. The other carotenoids have no vitamin activity.[4]

Definition

“Vitamin A” is a fat-soluble vitamin, a category that includes vitamins A, D, E and K. The vitamin encompasses several chemically related naturally occurring compounds or metabolies, i.e., vitamers, that all contain a β-ionone ring. The primary dietary form is retinol, which may have a fatty acid molecule attached, creating a retinyl ester, when stored in the liver. Retinol, the transport and storage form of vitamin A, is interconvertible with retinal, catalyzed to retinal by retinol dehydrogenases and back to retinol by retinaldehyde reductases.[8]

retinal + NADPH + H+ ⇌ retinol + NADP+
retinol + NAD+ ⇌ retinal + NADH + H+

Retinal, (also known as retinaldehyde) can be irreversibly converted to all-trans retinoic acid by the action of retinal dehydrogenase

retinal + NAD+ + H2O

Retinoic acid diffuses into the cell nucleus where it up- or down-regulates more than 500 genes by binding directly to gene targets via retinoic acid receptors.[4]

In addition to retinol, retinal and retinoic acid, there are plant-, fungi- or bacteria-sourced carotenoids which can be metabolized to retinol, and are thus vitamin A vitamrs. These carotenoids also exist in tissues and have antioxidant activity separate from the provitamin role.[9]

There are also what are referred to as 2nd, 3rd and 4th generation retinoids which are not considered vitamin A vitamers because they cannot be converted to retinol, retinal or all-trans retinoic acid. Some are prescription drugs for various indications. Examples: etretinate, acitretin, adapalene, bexarotene, tazarotene and Trifarotene

Absorption, metabolism and excretion

Retinyl esters from animal-sourced foods or synthesized for dietary supplements are acted upon by retinyl ester hydrolases in the lumen of the small intestine to release free retinol. Retinol enters intestinal absorptive cells by passive diffusion. Absorption efficency is in the range of 70 to 90%.[3] Within the cell, retinol is there bound to retinol binding protein 2 (RBP2). It is then enzymatically reesterified by action of lecithin retinol acyltransferase and incorporated into chylomicrons that are secreted into the lymphatic system. Unlike for retinol, β-carotene is taken up by enterocytes by the membrane transporter protein scavenger receptor B1 (SR-B1). The protein is upregulated in times of vitamin A deficiency. If vitamin A status is in the normal range, SR-B1 is downregulated, reducing absorption. Also downregulated is the enzyme resonsible for symetrically cleaving β-carotene into retinal. Absorbed β-carotene is then either incorporated as such into chylomicrons or first converted to retinal and then retinol, bound to RBP2. After a meal, roughly two-thirds of the chylomicrons are taken up by the liver with the remainder delivered to peripheral tissues. Peripheral tissues have the capacity to convert chylomicron β-carotene to retinol.[4][10]

The capacity to store retinol in the liver means that well-nourished humans can go months on a vitamin A deficient diet without manifesting signs and symptoms of deficiency. Two liver cell types are responsible for storage and release: hepatocytes and hepatic stellate cells (HSCs). Hepatocytes take up the lipid-rich chylomicrons, bind retinol to retinol-binding protein 4 (RBP4), and transfer the retinol-RBP4 to HSCs for storage in lipid droplets as retinyl esters. Mobilization reverses the process: retinyl ester hydrolase releases free retinol which is transferred to hypatocytes, bound to RBP4 and put into blood circulation. Under normal conditions, more than 95% of retinol in circulation is bound to RBP4.[10] Carnivores manage vitamin A differently. Carnivores are more tolerant of high intakes of retinol via the ability to excrete retinol and retinyl esters in urine. Carnivores also have the ability to store more in liver, due to a higher ratio of liver HSCs to hepatocytes compared to omnivores and herbivores. For humans, liver content can range from 20-30 μg/gram wet weight. Notoriously, polar bear liver is acutely toxic to humans because content has been reported in range of 2,215 to 10,400 μg/g wet weight.[11] As noted, in humans, retinol circulates bound to RBP4. Carnivores maintain R-RBP4 within a tight range while also having retinyl esters in circulation. Bound retinol is delivered to cells while the esters are excreted in urine.[11]

In the liver and peripheral tissues, retinol is reversibly converted to retinal by action of alcohol dehydrogenases (ADHs), which are also responsible for conversion of ethanol to acetaldehyde. Retinal is irreversibly oxidized to retinoic acid (RA) by action of aldehyde dehydrogenases (ALDHs). The oxidative degradation of RA is induced by RA – its presence triggers its removal, making for a short-acting gene transcription signal. This deactivation is mediated by a cytochrome P450 (CYP) enzyme system, specifically enzymes CYP26A1, CYP26B1 and CYP26C1. CYP26A1 is the predominant form in human liver; all other human adult tissues contained higher levels of CYP26B1. CYP26C1 is expressed mainly during embryonic development. All three convert retinoic acid into 4-oxo-RA, 4-OH-RA and 18-OH-RA.[12] Glucuronic acid forms water-soluble glucuronide conjugates with the oxidized metabolites, which are then excreted in urine and feces.

Metabolic functions

Other than for vision, the metabolic functions of vitamin A are mediated by retinoic acid (RA). The formation of RA from retinal is irreversible. To prevent accumulation of RA, it must be oxidized and eliminated. Three cytochromes catalyze the oxidation of retinoic acid. The genes for Cyp26A1, Cyp26B1 and Cyp26C1 are induced by high levels of RA, providing a self-regulating feedback loop.[13][14]

Vision and eye health

Vitamin A status involves eye health via two separate functions. Retinal is an essential factor in rod cells and cone cells in the retina responding to light exposure by sending nerve signals to the brain. An early sign of vitamin A deficiency is night blindness.[4] Vitamin A in the form of retinoic acid is essential to normal epithelial cell functions. Severe vitamin A deficiency, common in infants and young children in southeast Asia causes xerophthalmia characterized by dryness of the conjunctival epithelium and cornea. Untreated, xerophthalmia progresses to corneal ulceration and blindness.[15]

Vision

The role of vitamin A in the visual cycle is specifically related to the retinal compound. Retinol is converted by the enzyme RPE65 within the retinal pigment epithelium into 11-cis-retinal. Within the eye, 11-cis-retinal is bound to the protein opsin to form rhodopsin in rod cells and iodopsin in cone cells. As light enters the eye, the 11-cis-retinal is isomerized to the all-trans form. The all-trans retinal dissociates from the opsin in a series of steps called photo-bleaching. This isomerization induces a nervous signal along the optic nerve to the visual center of the brain. After separating from opsin, the all-trans-retinal is recycled and converted back to the 11-cis-retinal form by a series of enzymatic reactions. which then completes the cycle by binding to opsin to reform rhodopsin in the retina.[4] In addition, some of the all-trans retinal may be converted to all-trans retinol form and then transported with an interphotoreceptor retinol-binding protein to the retinal pigmented epithelial cells. Further esterification into all-trans retinyl esters allow for storage of all-trans-retinol within the pigment epithelial cells to be reused when needed. It is for this reason that a deficiency in vitamin A will inhibit the reformation of rhodopsin, and will lead to one of the first symptoms, night blindness.[4][16][17]

Night blindness

Vitamin A deficiency (VAD) caused night blindness is a reversible difficulty for the eyes to adjust to dim light. It is common in young children who have a diet inadequate in retinol and beta-carotene. A process called dark adaptation typically causes an increase in photopigment amounts in response to low levels of illumination. This increases light sensitivity by up to 100,000 times compared to normal daylight conditions. Significant improvement in night vision takes place within ten minutes, but the process can take up to two hours to reach maximal effect.[5] People expecting to work in a dark environment wore red-tinted goggles or were in a red light environment to not reverse the adaptation, because red light does not deplete rhodopsin versus what occurs with yellow or green light.[17]

Xerophthalmia and childhood blindness

220px Typical location of Bitot%27s spots

Typical location of Bitot’s spots

Xerophthalmia, caused by a severe vitamin A deficiency, is described by pathologic dryness of the conjunctival epithelium and cornea. The conjunctiva becomes dry, thick and wrinkled. Indicative is the appearance of Bitot’s spots, which are clumps of keratin debris that build up inside the conjunctiva. If untreated, xerophthalmia can lead to dry eye syndrome, corneal ulceration and ultimately to blindness as a result of corneal and retinal damage.

Throughout southeast Asia, estimates are that more than half of children under the age of six years have subclinical vitamin A deficiency and night blindness, with progression to xerophthalmia being the leading cause of preventable childhood blindness.[18] Estimates are that each year there are 350,000 cases of childhood blindness due to vitamin A deficiency.[15] The causes are vitamin A deficiency during pregnancy, followed by low transfer of vitamin A during lactation and infant/child diets low in vitamin A or beta-carotene.[18][15] The prevalence of pre-school age children who are blind due to vitamin A deficiency is lower than expected from incidence of new cases only because childhood vitamin A deficiency significantly increases all-cause mortality.[15]

According to a 2017 Cochrane review, vitamin A deficiency, using serum retinol less than 0.70 µmol/L as a criteria, is a major public health problem affecting an estimated 190 million children under five years of age in low- and middle-income countries, primarily in Sub-Saharan Africa and southeast Asia. In lieu of or in combination with food fortification programs, many countries have implemented public health programs in which children are periodically given very large oral doses of synthetic vitamin A, usually retinyl palmitate, as a means of preventing and treating VAD. Doses were 50,000 to 100,000 IU for children aged 6 to 11 months and 100,000 to 200,000 IU for children aged 12 months to five years, the latter typically every four to six months. In addition to a 24% reduction in all-cause mortality, eye-related results were reported. Prevalence of Bitot’s spots at follow-up were reduced by 58%, night blindness by 68%, xerophthalmia by 69%.[19]

Gene regulation

All-trans-retinoic acid (RA) regulates gene transcription by binding to nuclear receptors known as retinoic acid receptors (RARs; RARα, RARβ, RARγ) which are bound to DNA as heterodimers with retinoid “X” receptors (RXRs; RXRα, RXRβ, RXRγ). RARs and RXRs must dimerize before they can bind to the DNA. Expression of more than 500 genes are responsive to retinoic acid.[4] The process is that RAR-RXR heterodimers recognize retinoic acid response elements on DNA.[20] The receptors undergo a conformational change that causes co-repressors to dissociate from the receptors. Coactivators can then bind to the receptor complex, which may help to loosen the chromatin structure from the histones or may interact with the transcriptional machinery.[21] This response upregulates or downregulates the expression of target genes, including the genes that encode for the receptors themselves.[16] To precent excess accumulation of RA it must be metabolized and eliminated. Three cytochromes (Cyp26A1, Cyp26B1 Cyp26C1) catalyze the oxidation of RA. The genes for these proteins are induced by high concentrations of RA, thus providing a regulatory feedback mechanism.[4]

Immune function

Historically, vitamin A deficiency (VAD) has been linked to compromising resistance to infectious diseases.[22][23] In countries where early childhood VAD is common, vitamin A supplementation (VAS) public health programs initiated in the 1980s were shown to reduce all-cause mortality and incidence of diarrhea and measles.[19][24][25] Reviews based on in vitro and animal research describe the roles that vitamin A, as all-trans retinoic acid RA, plays in the proliferation and differentiation of white blood cells of the immune system, the directed movement of T cells to the intestinal system, and to the up- and down-regulation of lymphocyte function.[22][23][24][25][26][27] Lymphocytes and monocytes are types of white blood cell of the immune system.[28] Lymphocytes include natural killer cells, which function in innate immunity, T cells for adaptive cellular immunity and B cells for antibody-driven adaptive humoral immunity. Monocytes differentiate into macrophages and dendritic cells. Both types of white blood cells are created in bone marrow, then move into the blood stream. RA triggering of receptors in bone marrow is essential for hematopoiesis.[29] Some lymphocytes migrate to the thymus where they differentiate several types of T cells, in some instances referred to as “killer” or “helper” T cells and further differentiate after leaving the thymus. Each subtype has functions driven by the types of cytokines secreted and organs to which the cells preferentially migrate, also described as trafficking or homing.[30][31]

Retinoic acid drives T helper cell differentiation. If RA is adequate, subtype Th1 is suppressed and Th2, Th17 and Treg (for regulatory) are induced. The net effect is a down-regulation of immune activity, seen as tolerance of non-self food proteins and tolerance of resident bacteria and other organisms in the microbiome of the large intestine. If RA is not adequate, the consequences are pro-inflammatory and can contribute to allergic reactions and autoimmune activity, wherein the immune system reacts to cells of the host person.[22][23][26]

Research on the effects of vitamin A deficiency on impaired lymphocyte homing to the intestinal system dates back to animal research in the early 1980s in which it was shown that mesenteric lymph node cells collected from vitamin A deficient animals, then radio-isotope labeled, had a reduced capacity to accrue in the intestinal tract of vitamin A sufficient recipients.[32] More recent animal research has demonstrated that dendritic cells located in intestinal tissue have enzymes that convert retinal to all-trans retinoic acid, to be taken up by retinoic acid receptors on lymphocytes. The process triggers gene expression that leads to T cell types Th2, Th17 and iTreg moving to and taking up residence in mesenteric lymph nodes and Peyer’s patches, respectively outside and on the inner wall of the small intestine.[24][25] Dendritic cells also contribute to innate immunity.[27] In a vitamin A deficient state, innate immunity is compromised, RA signaling is absent, and pro-inflammatory Th1 cells predominate.[22][27]

Skin

Deficiencies in vitamin A have been linked to an increased susceptibility to skin infection and inflammation.[33] Vitamin A appears to modulate the innate immune response and maintains homeostasis of epithelial tissues and mucosa through its metabolite, retinoic acid (RA). As part of the innate immune system, toll-like receptors in skin cells respond to pathogens and cell damage by inducing a pro-inflammatory immune response which includes increased RA production.[33] The epithelium of the skin encounters bacteria, fungi and viruses. Keratinocytes of the epidermal layer of the skin produce and secrete antimicrobial peptides (AMPs). Production of AMPs resistin and cathelicidin, are promoted by RA.[33] Another way that vitamin A helps maintain a healthy skin and hair follicle microbiome, especially on the face, is by reduction of sebum secretion, which is a nutrient source for bacteria.[33]

Units of measurement

As some carotenoids can be converted into vitamin A, attempts have been made to determine how much of them in the diet is equivalent to a particular amount of retinol, so that comparisons can be made of the benefit of different foods. The situation can be confusing because the accepted equivalences have changed over time

For many years, a system of equivalencies in which an international unit (IU) was equal to 0.3 μg of retinol (~1 nmol), 0.6 μg of β-carotene, or 1.2 μg of other provitamin-A carotenoids was used.[34] This relationship was alternatively expressed by the retinol equivalent (RE): one RE corresponded to 1 μg retinol, to 2 μg β-carotene dissolved in oil, to 6 μg β-carotene in foods, and to 12 μg of either α-carotene, γ-carotene, or β-cryptoxanthin in food.

Newer research has shown that the absorption of provitamin-A carotenoids is only half as much as previously thought. As a result, in 2001 the US Institute of Medicine recommended a new unit, the retinol activity equivalent (RAE). Each μg RAE corresponds to 1 μg retinol, 2 μg of β-carotene in oil, 12 μg of “dietary” beta-carotene, or 24 μg of the three other dietary provitamin-A carotenoids.[3]

Substance and its chemical environment (per 1 μg) IU (1989) μg RE (1989) μg RAE (2001)
Retinol 3.33 1 1
beta-Carotene, dissolved in oil 1.67 1/2 1/2
beta-Carotene, common dietary 1.67 1/6 1/12
  • alpha-Carotene, common dietary
  • gamma-Carotene, common dietary
  • beta-Cryptoxanthin, common dietary
0.83 1/12 1/24

Because the conversion of retinol from provitamin carotenoids by the human body is actively regulated by the amount of retinol available to the body, the conversions apply strictly only for vitamin A-deficient humans.[citation needed]

Dietary recommendations

The US National Academy of Medicine updated Dietary Reference Intakes (DRIs) in 2001 for vitamin A, which included Recommended Dietary Allowances (RDAs).[3] For infants up to 12 months there was not sufficient information to establish a RDA, so Adequate Intake (AI) is shown instead. As for safety, tolerable upper intake levels (ULs) were also established. For RDAs, the calculation of retinol activity equivalents (RAE) is each μg RAE corresponds to 1 μg retinol, 2 μg of β-carotene in oil, 12 μg of “dietary” beta-carotene, or 24 μg of the three other dietary provitamin-A carotenoids.[3] For ULs, carotenoids are not added when calculating total vitamin A intake for safety assessments.[3]

Life stage group US RDAs or AIs
(μg RAE/day)
US Upper limits
(μg/day)
Infants 0–6 months 400 (AI) 600
7–12 months 500 (AI) 600
Children 1–3 years 300 600
4–8 years 400 900
Males 9–13 years 600 1700
14–18 years 900 2800
>19 years 900 3000
Females 9–13 years 600 1700
14–18 years 700 2800
>19 years 700 3000
Pregnancy <19 years 750 2800
>19 years 770 3000
Lactation <19 years 1200 2800
>19 years 1300 3000

The European Food Safety Authority (EFSA) refers to the collective set of information as Dietary Reference Values, with Population Reference Intake (PRI) instead of RDA, and Average Requirement instead of EAR. AI and UL defined the same as in United States. For women and men of ages 15 and older, the PRIs are set respectively at 650 and 750 μg RE/day. PRI for pregnancy is 700 μg RE/day, for lactation 1300/day. For children of ages 1–14 years, the PRIs increase with age from 250 to 600 μg RE/day. These PRIs are similar to the US RDAs.[35] The EFSA reviewed the same safety question as the United States, and set ULs at 800 for ages 1–3, 1100 for ages 4–6, 1500 for ages 7–10, 2000 for ages 11–14, 2600 for ages 15–17 and 3000 μg/day for ages 18 and older for preformed vitamin A, i.e., not including dietary contributions from carotenoids.[36]

Safety

Retinol safety

Vitamin A toxicity hypervitaminosis A occurs when there is too much vitamin A accumulating in the body. It comes from consumption of preformed vitamin A but not of carotenoids, as conversion of the latter to retinol is suppressed by the presence of adequate retinol. There are historical reports of acute hypervitaminosis from Artic explorers consuming seal or polar bear liver, both very rich sources of stored retinol,[37] but otherwise there is no risk from consuming too much via foods. Only consumption of retinol-containing dietary supplements can result in acute or chronic toxicity.[4] Acute toxicity occurs after a single or short-term doses of greater than 150,000 μg. Symptoms include blurred vision, nausea, vomiting, dizziness and headache within 8 to 24 hours. For infants ages 0–6 months given an oral dose to prevent development of vitamin A deficiency, bulging skull fontanel was evident after 24 hours, usually resolved by 72 hours.[38] Chronic toxicity may occur with long-term consumption of vitamin A at doses of 25,000–33,000 IU/day for several months.[2] Excessive consumption of alcohol can lead to chronic toxicity at lower intakes.[6] Symptoms may include nervous system effects, liver abnormalities, fatigue, muscle weakness, bone and skin changes and others. The asverse effects of both acute an chronic toxicity are reversed after consumption is stopped.[3]

In 2001, for the purpose of determining ULs for adults, the US Institute of Medicine considered three primary adverse effects and settled on two: teratogenicity, i.e., causing birth defects, and liver abnormalities. Reduced bone mineral density was considered, but dismissed because the human evidence was contradictory.[3] During pregnancy, especially during the first trimester, consumption of retinol in amounts exceeding 4,500 μg/day increased the risk of birth defects, but not below that amount, thus setting a “No-Observed Adverse-Effect Level” (NOAEL). Given the quality of the clinical trial evidence, the NOAEL was divided by an uncertainty factor of 1.5 to set the UL for women of reproductive age at 3,000 μg/day of preformed vitamin A. For all other adults, liver abnormalities were detected at intakes above 14,000 μg/day. Given the weak quality of the clinical evidence, an uncertainty factor of 5 was used, and with rounding, the UL was set at 3,000 μg/day. Despite a US UL set at 3,000 μg, it is possible to buy over-the-counter dietary supplement products which are 7,500 μg (25,000 IU), with a label caution statement “Not intended for long term use unless under medical supervision.”[39]

For children ULs were extrapolated from the adult value, adjusted for relative body weight. For infants, several case studies reported adverse effects that include bulging fontanels, increased intracranial pressure, loss of appetite, hyperirritability and skin peeling after chronic ingestion of the order of 6,000 or more μg/day. Given the small database, an uncertainty factor of 10 divided into the “Lowest-Observed-Adverse-Effect Level” (LOAEL) led to a UL of 600 μg/day.[3]

β-carotene safety

No adverse effects other than carotenemia have been reported for consumption of β-carotene rich foods. Supplementation with β-carotene does not cause hypervitaminosis A. Two large clinical trials (ATBC and CARET) were conducted in tobacco smokers to see if years of β-carotene supplementation at 20 or 30 mg/day in oil-filled capsules would reduce the risk of lung cancer.[40] These trials were implemented because observational studies had reported a lower incidence of lung cancer in tobacco smokers who had diets higher in β-carotene. Unexpectedly, this high-dose β-carotene supplementation resulted in a higher incidence of lung cancer and of total mortality.[9] Taking this and other evidence into consideration, the U.S. Institute of Medicine decided to not set a Tolerable Upper Intake Level (UL) for β-carotene.[9][40] The European Food Safety Authority, acting for the European Union, also decided to not set a UL for β-carotene.[36]

250px Carrots

Carrots are a rich source of beta-carotene

Carotenosis

Carotenoderma, also referred to as carotenemia, is a benign and reversible medical condition where an excess of dietary carotenoids results in orange discoloration of the outermost skin layer. It is associated with a high blood β-carotene value. This can occur after a month or two of consumption of beta-carotene rich foods, such as carrots, carrot juice, tangerine juice, mangos, or in Africa, red palm oil. β-carotene dietary supplements can have the same effect. The discoloration extends to palms and soles of feet, but not to the white of the eye, which helps distinguish the condition from jaundice.[41] Consumption of greater than 30 mg/day for a prolonged period has been confirmed as leading to carotenemia.[9][42]

U.S. labeling

For U.S. food and dietary supplement labeling purposes, the amount in a serving is expressed as a percent of Daily Value (%DV). For vitamin A labeling purposes 100% of the Daily Value was set at 5,000 IU, but it was revised to 900 μg RAE on 27 May 2016.[43][44] A table of the old and new adult daily values is provided at Reference Daily Intake.

Sources

Source Retinol activity equivalents
(RAEs), μg/100g
μg = microgram
cod liver oil 30000
beef liver (cooked) 21145
turkey liver (cooked) 10751
chicken liver (cooked) 4296
sweet potato (cooked in skin) 961
carrot (raw) 835
pumpkin (canned) 778
butter (stick) 684
spinach (cooked) 603
cheddar cheese 316
cantaloupe melon 169
bell pepper (raw) red, orange, yellow 157
egg (cooked) 140

Vitamin A is found in many foods (table).[45] Vitamin A in food exists either as preformed retinol – an active form of vitamin A – found in animal liver, dairy and egg products, and some fortified foods, or as provitamin A carotenoids, which are plant pigments digested into vitamin A after consuming carotenoid-rich plant foods, typically in red, orange, or yellow colors.[2] Carotenoid pigments may be masked by chlorophylls in dark green leaf vegetables, such as spinach. The relatively low bioavailability of plant-food carotenoids results partly from binding to proteins – chopping, homogenizing or cooking disrupts the plant proteins, increasing provitamin A carotenoid bioavailability.[2]

Retinol activity equivalent (RAE) represents vitamin A activity as retinol.[2] Twelve micrograms (μg) of beta-carotene in plant foods are needed to supply one microgram of retinol, giving dietary beta-carotene an RAE ratio of 12:1. Two micrograms of beta-carotene in oil as a dietary supplement are converted in the body to one microgram of retinol, giving it an RAE ratio of 2:1.[2] Conversion of carotenoids to retinol varies from person to person, depending on genetic factors and vitamin status.[2][46][47]

According to the vitamin A chapter in the Dietary Reference Intakes book, a vegetarian or vegan diet can provide sufficient vitamin A in the form of provitamin A carotenoids if the diet contains green leafy vegetables, carrots, sweet potatoes, and other carotenoid-rich foods (table). Some manufactured foods and dietary supplements are sources of vitamin A or beta-carotene.[2][3]

Despite the US setting an adult upper limit of 3,000 μg/day, many companies sell vitamin A as a dietary supplement with amounts of 7,500 μg/day.[citation needed]

Fortification

Some countries require or recommend fortification of foods. As of January 2022, 37 countries, mostly in Sub-Saharan Africa, require food fortification of cooking oil, rice, wheat flour or maize (corn) flour with vitamin A, usually as retinyl palmitate or retinyl acetate. Examples include Pakistan, oil, 11.7 mg/kg and Nigeria, oil, 6 mg/kg; wheat and maize flour, 2 mg/kg.[48] An additional 12 countries, mostly in southeast Asia have a voluntary fortification program. For example, the government of India recommends 7.95 mg/kg in oil and 0.626 mg/kg for wheat flour and rice. However, compliance in countries with voluntary fortification is lower than countries with mandatory fortification.[48] No countries in Europe or North America fortify foods with vitamin A.[48]

Separated from fortification via addition of synthetic vitamin A to foods, means of fortifying foods via genetic engineering have been explored. Research on rice began in 1982.[49] The first field trials of golden rice cultivars were conducted in 2004.[50] The result was “Golden Rice”, a variety of Oryza sativa rice produced through genetic engineering to biosynthesize beta-carotene, a precursor of retinol, in the edible parts of rice.[51][52] In May 2018, regulatory agencies in the United States, Canada, Australia and New Zealand had concluded that Golden Rice met food safety standards.[53] On 21 July 2021, the Philippines became the first country to officially issue the biosafety permit for commercially propagating Golden Rice.[54][55]

Vitamin A supplementation (VAS)

350px Vitamin A supplementation coverage rate %28children ages 6 59 months%29%2C OWID.svg

Vitamin A supplementation coverage rate (children ages 6–59 months), 2014[56]

Delivery of oral high-dose supplements remains the principal strategy for minimizing deficiency.[57] As of 2017, more than 80 countries worldwide are implementing universal VAS programs targeted to children 6–59 months of age through semi-annual national campaigns.[58]

Deficiency

Primary causes

Vitamin A deficiency is common in developing countries, especially in Sub-Saharan Africa and Southeast Asia. Deficiency can occur at any age, but is most common in pre-school-age children and pregnant woman, the latter due to a need to transfer retinol to the fetus. The causes are low intake of retinol-containing, animal-sourced foods and low intake of carotene-containing, plant-sourced foods. Vitamin A deficiency is estimated to affect approximately one third of children under the age of five around the world,[59] possibly leading to the deaths of 670,000 children under five annually.[60]

Between 250,000 and 500,000 children in developing countries become blind each year owing to vitamin A deficiency.[6] Vitamin A deficiency is “the leading cause of preventable childhood blindness”, according to UNICEF.[61][62] It also increases the risk of death from common childhood conditions, such as diarrhea. UNICEF regards addressing vitamin A deficiency as critical to reducing child mortality, the fourth of the United Nations’ Millennium Development Goals.[61]

During diagnosis, night blindness and dry eyes are signs of vitamin A deficiency that can be recognized without requiring biochemical tests. Plasma retinol is used to to confirm vitamin A status. A plasma concentration of about 2.0 μmol/L is normal; less than 0.70 μmol/L (equivalent to 20 μg/dL) indicates moderate vitamin A deficiency, and less than 0.35 μmol/L (10 μg/dL) indicates severe vitamin A deficiency. Breast milk retinol of less than 8 μg/gram milk fat is considered insufficient.[4] One weakness of these measures is that they are not good indicators of liver vitamin A stores as retinyl esters in hepatic stellate cells. The amount of vitamin A leaving the liver, bound to retinol binding protein (RBP), is under tight control as long as there are sufficient liver reserves. Only when liver content of vitamin A drops below approximately 20 μg/gram will concentration in the blood decline.[3]

Secondary causes

There are causes for deficiency other than low dietary intake of vitamin A as retinol or carotenes. Inadequate dietary protein and caloric energy are needed for a normal rate of synthesis of RBP, without which, retinol cannot be mobilized to leave the liver. Systemic infections can cause transient decreases in RBP synthesis even if protein-calorie malnutrition is absent. Chronic alcohol consumption reduces liver vitamin A storage.[3] Non-alcoholic fatty liver disease (NAFLD), characterized by the accumulation of fat in the liver, is the hepatic manifestation of metabolic syndrome. Liver damage from NAFLD reduces liver storage capacity for retinol and reduces the ability to mobilize liver stores to maintain normal circulating concentration.[63]

Medical uses

Preventing and treating deficiency

Recognition of its prevalence and consequences has led to governments and non-government organizations promoting vitamin A fortification of foods[48] and creating programs that administer large bolus-size oral doses of vitamin A to young children every four to six months.[58] In 2008, the World Health Organization estimated that vitamin A supplementation over a decade in 40 countries averted 1.25 million deaths due to vitamin A deficiency.[64] A Cochrane review reported that vitamin A supplementation is associated with a clinically meaningful reduction in morbidity and mortality in children ages six month to five years of age. All-cause mortality was reduced by 24%, and incidences of diarrhea and measles by 15% and 50%, respectively.[19] However, a Cochrane review by the same group concluded there was insufficient evidence to recommend blanket vitamin A supplementation for infants one to six months of age, as it did not reduce infant mortality or morbidity.[38]

Oral retinoic acid

Orally consumed retinoic acid (RA), as all-trans tretinoin or 13-cis isotretinoin has been shown to improve facial skin health by switching on genes and differentiating keratinocytes (immature skin cells) into mature epidermal cells. RA reduces the size and secretion of the sebaceous glands, and by doing so reduces bacterial numbers in both the ducts and skin surface. It reduces inflammation via inhibition of chemotactic responses of monocytes and neutrophils. In the US, isotretinoin was released to the market in 1982 as a revolutionary treatment for severe and refractory acne vulgaris. It was shown that a dose of 0.5‑1.0 mg/kg body weight/day is enough to produce a reduction in sebum excretion by 90% within a month or two, but the recommended treatment duration is 4 to 6 months.[65] Isotretinoin is a known teratogen, with an estimated 20‑35% risk of physical birth defects to infants that are exposed to isotretinoin in utero, including numerous congenital defects such as craniofacial defects, cardiovascular and neurological malformations or thymic disorders.Neurocognitive impairments in the absence of any physical defects has been established to be 30‑60%. For these reasons, physician- and patient-education programs were initiated, recommending that for women of child-bearing age, contraception be initated a month before starting oral (or topical) isotretinoin, and continue for a month after treatment ended.[65]

In addition to the approved use for treating acne vulgaris, researchers have investigated off-label appications for dermatological conditions, such as rosacea, psoriasis, and other conditions.[66] Rosacea was reported as responding favorably to doses lower than used for acne. Isotretinoin in combination with ultraviolet light was shown affective for treating psoriasis. Isotretinoin in combination with injected interferon-alpha showed some potential for treating genital warts. Isotretinoin in combination with topical fluorouracil or injected interferon-alpha showed some potential for treating precancerous skin lesions and skin cancer.[66]

Topical retinoic acid and retinol

220px Retinoids.svg

Retinoids: Tretinoin is all-trans-retinoic acid; initial tradename: Retin-A. Isotretinoin is 13-cis-retinoic acid; initial tradename: Accutane. Etretinate and Acitretin, its non-esterified metabolite, are used orally to treat severe psoriasis.

Retinoic acids tretinoin (all-trans-retinoic acid) and isotretinoin (13-cis-retinoic acid) are prescription topical medications used to treat moderate to severe cystic acne and acne not responsive to other treatments.[67][68][69][70] These are usually applied as a skin cream to the face after cleansing to remove make-up and skin oils. Tretinoin and isotretinoin act by binding to two nuclear receptor families within keratinocytes: the retinoic acid receptors (RAR) and the retinoid X receptors (RXR).[71] These events contribute to the normalization of follicular keratinization and decreased cohesiveness of keratinocytes, resulting in reduced follicular occlusion and microcomedone formation.[72] The retinoid-receptor complex competes for coactivator proteins of AP-1, a key transcription factor involved in inflammation.[71] Retinoic acid products also reduce sebum secretion, a nutrient source for bacteria, from facial pores.[33]

These drugs are US-designated Pregnancy Category C (animal reproduction studies have shown an adverse effect on the fetus), and should not be used by pregnant women or women who are anticipating becoming pregnant.[73] Many countries established a physician- and patient- education pregnancy prevention policy.[74]

Non-prescription topical products that have health claims for reducing facial acne, combating skin dark spots and reducing wrinkles and lines associated with aging often contain retinyl palmitate. The hypothesis is that this is absorbed and desterified to free retinol, then converted to retinaldehyde and further metabolized to all-trans retinoic acid, whence it will have the same effects as prescription products with fewer side effects.[75] There is some ex vivo evidence with human skin that esterified retinol is absorbed and then converted to retinol.[76] In addition to esterified retinol, some of these products contain hydroxypinacolone retinoate, identified as esterified 9-cis retinoic acid.

Synthesis

Biosynthesis

Carotenoid synthesis takes place in plants, certain fungi, and bacteria. Structurally carotenes are tetraterpenes, meaning that they are synthesized biochemically from four 10-carbon terpene units, which in turn were formed from eight 5-carbon isoprene units. Intermediate steps are the creation of a 40-carbon phytoene molecule, conversion to lycopene via desaturation, and then creation of ionone rings at both ends of the molecule. β-carotene has a β-ionone ring at both ends, meaning that the molecule can be divided symmetrically to yield two retinol molecules. α-Carotene has a β-ionone ring at one end and an Ɛ-ionone ring at the other, so it has half the retinol conversion capacity.[9]

220px Chem 157 vitamin a synthesis project

Vitamin A biosynthesis from β-carotene

In most animal species, retinol is synthesized from the breakdown of the plant-formed provitamin, β-carotene. First, the enzyme beta-carotene 15,15′-dioxygenase (BCO-1) cleaves β-carotene at the central double bond, creating an epoxide. This epoxide is then attacked by water creating two hydroxyl groups in the center of the structure. The cleavage occurs when these alcohols are reduced to the aldehydes using NADH. The resultant retinal is then quickly reduced to retinol by the enzyme retinol dehydrogenase.[4] Omnivore species such as dogs, wolves, coyotes and foxes in general are low producers of BCO-1. The enzyme is lacking in felids (cats), meaning that vitamin A requirements are met from the retinyl ester content of prey animals.[11]

Industrial synthesis

220px Ionone beta.svg

β-ionone ring

β-carotene can be extracted from fungus Blakeslea trispora, marine algae Dunaliella salina or genetically modified bacteria of the genus Sphingomonas, or else via total synthesis using either a method developed by BASF[77][78] or a Grignard reaction utilized by Hoffman-La Roche.[79]

The world market for synthetic retinol is primarily for animal feed, leaving approximately 13% for a combination of food, prescription medication and dietary supplement use.[80] The first industrialized synthesis of retinol was achieved by the company Hoffmann-La Roche in 1947. In the following decades, eight other companies developed their own processes. β-ionone, synthesized from acetone, is the essential starting point for all industrial syntheses. Each process involves elongating the unsaturated carbon chain.[80] Pure retinol is extremely sensitive to oxidization and is prepared and transported at low temperatures and oxygen-free atmospheres. When prepared as a dietary supplement or food additive, retinol is stabilized as the ester derivatives retinyl acetate or retinyl palmitate. Prior to 1999, three companies, Roche, BASF and Rhone-Poulenc controlled 96% of global vitamin A sales. In 2001, the European Commission imposed total fines of 855.22 Euros on these and five other companies for their participation in eight distinct market-sharing and price-fixing cartels that dated back to 1989. Roche sold its vitamin division to DSM in 2003. DSM and BASF have the major share of industrial production.[80]

Research

Cancer

Meta-analyses of intervention and observational trials for various types of cancer report mixed results. Supplementation with β-carotene did not appear to decrease the risk of cancer overall, nor specific cancers including: pancreatic, colorectal, prostate, breast, melanoma, or skin cancer generally.[81] High-dose β-carotene supplementation unexpectedly resulted in a higher incidence of lung cancer and of total mortality in people who were cigarette smokers.[9]

For dietary retinol, no effects were observed for high dietary intake and breast cancer survival,[82] risk of liver cancer,[83] risk of bladder cancer[84] or risk of colorectal cancer,[85][86] although the last review did report lower risk for higher beta-carotene consumption.[86] In contrast, an inverse association was reported between retinol intake and relative risk of esophageal cancer,[87] gastric cancer,[88] ovarian cancer,[89] pancreatic cancer,[90] lung cancer,[91] melanoma,[92] and cervical cancer.[93] For lung cancer, an inverse association was also seen for beta-carotene intake, separate from the retinol results.[91] When high dietary intake was compared to low dietary intake, the decreases in relative risk were in the range of 15 to 20%. For gastric cancer, a meta-analysis of prevention trials reported a 29% decrease in relative risk from retinol suplementation at 1500 μg/day.[94]

Fetal alcohol spectrum disorder

Fetal alcohol spectrum disorder (FASD), formerly referred to as fetal alcohol syndrome, presents as craniofacial malformations, neurobehavioral disorders and mental disabilities, all attributed to exposing human embryos to alcohol during fetal development.[95][96] The risk of FASD depends on the amount consumed, the frequency of consumption, and the points in pregnancy at which the alcohol is consumed.[97] Ethanol is a known teratogen, i.e., causes birth defects. Ethanol is metabolized by alcohol dehydrogenase enzymes into acetaldehyde.[98][99] The subsequent oxidation of acetaldehyde into acetate is performed by aldehyde dehydrogenase enzymes. Given that retinoic acid (RA) regulates numerous embryonic and differentiation processes, one of the proposed mechanisms for the teratogenic effects of ethanol is a competition for the enzymes required for the biosynthesis of RA from vitamin A. Animal research demonstrates that in the embryo, the competition takes place between acetaldehyde and retinaldehyde for aldehyde dehydrogenase activity. In this model, acetaldehyde inhibits the production of retinoic acid by retinaldehyde dehydrogenase. Ethanol-induced developmental defects can be ameliorated by increasing the levels of retinol, retinaldehyde, or retinaldehyde dehydrogenase. Thus, animal research supports the reduction of retinoic acid activity as an etiological trigger in the induction of FASD.[95][96][100][101]

Malaria

Malaria and vitamin A deficiency are both common among young children in sub-Saharan Africa. Vitamin A supplementation to children in regions where vitamin A deficiency is common has repeatedly been shown to reduce overall mortality rates, especially from measles and diarrhea.[102] For malaria, clinical trial results are mixed, either showing that vitamin A treatment did not reduce the incidence of probable malarial fever, or else did not affect incidence, but did reduce slide-confirmed parasite density and reduced the number of fever episodes.[102] The question was raised as to whether malaria causes vitamin A deficiency, or vitamin A deficiency contributes to the severity of malaria, or both. Researchers proposed several mechanisms by which malaria (and other infections) could contribute to vitamin A deficiency, including a fever-induced reduction in synthesis of retinal-binding protein (RBP) responsible for transporting retinol from liver to plasma and tissues, but reported finding no evidence for a transient depression or restoration of plasma RBP or retinol after a malarial infection was eliminated.[102]

History

220px Frederick Gowland Hopkins nobel

Frederick Gowland Hopkins, 1929 Nobel Prize for Physiology or Medicine

In 1912, Frederick Gowland Hopkins demonstrated that unknown accessory factors found in milk, other than carbohydrates, proteins, and fats were necessary for growth in rats. Hopkins received a Nobel Prize for this discovery in 1929.[5][103] By 1913, one of these substances was independently discovered by Elmer McCollum and Marguerite Davis at the University of Wisconsin–Madison, and Lafayette Mendel and Thomas Burr Osborne at Yale University. McCollum and Davis ultimately received credit because they submitted their paper three weeks before Mendel and Osborne. Both papers appeared in the same issue of the Journal of Biological Chemistry in 1913.[104] The “accessory factors” were termed “fat soluble” in 1918 and later “vitamin A” in 1920. In 1919, Harry Steenbock (University of Wisconsin–Madison) proposed a relationship between yellow plant pigments (beta-carotene) and vitamin A. In 1931, Swiss chemist Paul Karrer described the chemical structure of vitamin A.[103] Retinoic acid and retinol were first synthesized in 1946 and 1947 by two Dutch chemists, David Adriaan van Dorp and Jozef Ferdinand Arens.[105][106]

220px George Wald nobel

George Wald, 1967 Nobel Prize for Physiology or Medicine

During World War II, German bombers would attack at night to evade British defenses. In order to keep the 1939 invention of a new on-board Airborne Intercept Radar system secret from German bombers, the British Ministry of Information told newspapers that the nighttime defensive success of Royal Air Force pilots was due to a high dietary intake of carrots rich in beta-carotene, propagating the myth that carrots enable people to see better in the dark.[107]

In 1967, George Wald shared the Nobel Prize in Physiology and Medicine for his work on chemical visual processes in the eye.[108] Wald had demonstrated in 1935 that photoreceptor cells in the eye contain rhodopsin, a chromophore composed of the protein opsin and 11-cis retinal. When struck by light, 11-cis retinal undergoes photoisomerization to all-trans retinal and via signal transduction cascade send a nerve signal to the brain. The all-trans retinal is reduced to all-trans retinol and travels back to the retinal pigment epithelium to be recycled to 11-cis retinal and reconjugated to opsin.[5][109] Wald’s work was the culmination of nearly 60 years of research. In 1877, Franz Christian Boll identified a light-sensitive pigment in the outer segments of rod cells of the retina that faded/bleached when exposed to light, but was restored after light exposure ceased. He suggested that this substance, by a photochemical process, conveyed the impression of light to the brain.[5] The research was taken up by Wilhelm Kühne, who named the pigment rhodopsin, also known as “visual purple.” Kühne confirmed that that rhodopsin is extremely sensitive to light, and thus enables vision in low-light conditions, and that it was this chemical decomposition that stimulated nerve impulses to the brain.[5] Research stalled until after identification of “fat-soluble vitamin A” as a dietary substance found in milkfat but not lard, would reverse night blindness and xerophthalmia. In 1925, Fridericia and Holm demonstrated that vitamin A deficient rats were unable to regenerate rhodopsin after being moved from a light to a dark room.[110]

  • Vitamin A at the US National Library of Medicine Medical Subject Headings (MeSH)
  • WHO publications on Vitamin A Deficiency